Hyalgan L/L and Panitumumab Intravenous
Determining the interaction of Hyalgan L/L and Panitumumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: sodium hyaluronate
Brand name: Durolane, Euflexxa, Gel-One, Gelsyn-3, Hyalgan, Supartz, Supartz FX, Visco-3, Trivisc, GenVisc 850, Monovisc, Orthovisc, Synvisc, Synvisc-One
Synonyms: Sodium hyaluronate (injection)
Generic Name: panitumumab
Brand name: Vectibix
Synonyms: Panitumumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hyalgan L/L-Panixine
- Hyalgan L/L-Panixine DisperDose
- Hyalgan L/L-Panlor
- Hyalgan L/L-Panlor Tablet
- Hyalgan L/L-Panlor Tablets
- Hyalgan L/L-Panlor-DC
- Panitumumab Intravenous-Hyaluronan
- Panitumumab Intravenous-Hyaluronate and Derivatives
- Panitumumab Intravenous-Hyaluronate and Derivatives Injection (Knee)
- Panitumumab Intravenous-Hyaluronate sodium Injection
- Panitumumab Intravenous-Hyaluronidase
- Panitumumab Intravenous-Hyaluronidase and immune globulin